Login

Christophe INIZAN of La Française AM discusses European commercial real estate investment strategies. 00:10:00

Share On Facebook Share On Twitter

Guillaume CADIOU is Chairman of La Française Group

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Peter Altabef, Chairman and CEO of Unisys Corporation, highlights the company's 147-year history and its long-standing presence on the NYSE in a NYSE Floor Talk.
00:10:00
CTO Chairman at Invest Nest: Unlocking Citigold's Potential | Mr Mark J Lynch – Executive Chairman of Citigold corporation ltd
00:10:00
Navigating Interest Rate Dynamics and Mediobanca Opportunities | Alberto Nicola Nagel, CEO, Mediobanca .
00:10:00
Funds businesses transforming industry verticals|Will McClelland,Co-Founder & General Partner,Elizabeth Street Ventures
00:10:00
Talking about recent mining results, expansion plans in Argentina, and mining of Bitcoin and Ethereum, Bitfarms | Geoff Morphy, CEO, Bitfarms LtdBFARF:PKC
00:10:00
How Kovac Provides Unmatched Support and Freedom for Financial Advisors
00:10:00
Barclays CEO Discusses Shifts in Banking Landscape and Strategic Focus | C.S. Venkatakrishnan , CEO , Barclays.
00:10:00
Driving Digital Transformation: Revolutionizing Consumer Engagement and Decision-Making at OBL|Mr. Aditya Gupta,Chief Executive Officer,Orient Bell Ltd.
00:10:00
Exploring Newfrontiers: Exploits Gold's Strategic Approach to Gold Discovery in Newfoundland and Labrador
00:10:00
Exploring Asia's Investment Opportunities with Legg Mason Asset Management | Lennie Lim and Freeman Tsang
00:10:00
Early Stages of Commercial Real Estate Reset Concerns.
00:10:00
Scott Voss on the Evolution and Performance of Primary Private Equity Investments | Scott Voss, Managing Director, HarbourVest Partners.

© 2026 Nehu